Professor, Internal Medicine, St Louis University School of Medicine
Endocrinology
Dr. George T. Griffing, MD
|
|
Give Review
George Griffing works in the field of Endocrinology. He went to medical school at Wayne State University School of Medicine. Wayne State University School of Medicine has a rank of 63 in research and a 85 in primary care He received awards:"Regional Top Doctor", "Meaningful Use Stage 1 Certification" and "Diabetes Recognition Program". George T. Griffing is also published. He has 69 publications published. The lastest publication: "Computerized management of diabetes: a synthesis of controlled trials.'
Publications
- Images in clinical medicine. Frank's sign.
- "Hyper-Warburgism," a Cause of Asymptomatic Hypoglycemia with Lactic Acidosis in a Patient with Non-Hodgkin's Lymphoma.
- Seven habits (to break) of highly effective people.
- Doctor, you should now measure abdominal height.
- Fibromyalgia is not a rheumatologic Disease anymore.
- Mother was right about cod liver oil.
- Human growth hormone: a Paul Bunyan drug or a drug for Paul's bunion.
- Endocannabinoids--the brain's own marijuana--may be linked to the metabolic Syndrome.
- Effect of peripheral sex steroid Metabolism on pituitary gonadotropin reserve of women with hypothalamic amenorrhea.
- Metabolic clearance rates of androgens and oestrogens in ageing women.
- Production rates of androgens and oestrogens in post-menopausal women.
- Computerized management of Diabetes: a synthesis of controlled trials.
- Effectiveness of indapamide versus enalapril as second-step therapy of systemic hypertension.
- Could intranasal insulin be useful in the treatment of non-insulin-dependent Diabetes mellitus?
- Enalapril and hypertension.
- Enalapril (MK-421) and the white cell count and haematocrit.
- 19-nor-deoxycorticosterone excretion in healthy and hypertensive subjects.
- Primary empty sella Syndrome, ACTH hypersecretion, and normal adrenocortical function. Report of two cases.
- Temporal enhancement of renin-aldosterone blockade by enalapril, an angiotensin-converting enzyme inhibitor.
- Altered fractional tetrahydroaldosterone excretion during pharmacological blockade and activation of the renin-aldosterone system.
- 19-Nor-corticosteroids in experimental and human hypertension.
- The regulation of urinary free 19-nor-deoxycorticosterone and its relation to systemic arterial blood pressure in normotensive and hypertensive subjects.
- Reversal of diuretic-induced Secondary hyperaldosteronism and hypokalemia by enalapril (MK-421): a new angiotensin-converting enzyme inhibitor.
- The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing Hypokalemia associated with primary and se...
- Plasma and urinary 19-nor-deoxycorticosterone in 17 alpha-hydroxylase deficiency Syndrome.
- 19-Nor-corticosteroids in health, in hypertensive states in humans including 17 alpha-hydroxylase deficiency and in the spontaneously hypertensive rat (SHR).
- 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
- The effects of hydrochlorothiazide on the renin-aldosterone system.
- Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
- Transitory increment in urinary free 19-nor-deoxycorticosterone after diuretic-induced renin stimulation.
- The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's Syndrome.
- Comparison of the mineralocorticoid activity of 19-oxygenated and 19-nor derivatives of deoxycorticosterone.
- Hirsutism causes and treatments.
- Elevated 18-hydroxy-corticosterone in inbred salt-sensitive rats.
- Antihypertensive effects of an aromatase inhibitor in inbred salt-sensitive rats.
- Alterations in aldosterone secretion and Metabolism in low renin hypertension.
- Cisplatin-based treatment of adrenocortical carcinoma.
- Renal 21-hydroxylation of 19-hydroxy-progesterone to 19-hydroxy-deoxycorticosterone.
- An Adrenal cyst associated with 19-nor-deoxycorticosterone excess and low renin hypertension.
- Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by trilostane, an inhibitor of Adrenal steroidogenesis.
- 19-Hydroxylase inhibition of Adrenal mitochondrial P450 11 beta/18/19-hydroxylase by a suicide inhibitor.
- Plasma beta-endorphin levels in primary aldosteronism.
- Converting-enzyme inhibitor administration lowers urinary free 19-nor-deoxycorticosterone levels.
- Discordance of plasma DHEA-S, DHEA, and cortisol responses with various ACTH regimens.
- Biphasic plasma aldosterone responses to four single-dose ACTH regimens.
- The therapeutic effect of a new angiotensin-converting enzyme inhibitor, enalapril maleate, in idiopathic Hyperaldosteronism.
- Identification of 19-hydroxy-progesterone in human placenta.
- Selective 19-hydroxylase inhibition by an aromatase inhibitor, 4-hydroxyandrostenedione.
- Biphasic 19-nor-deoxycorticosterone excretion after Adrenal enucleation is associated with altered Adrenal mitochondrial cytochrome P450 11 beta-, 18-, and 19-hydroxyl...
- Elevated urinary 19-Nor-deoxycorticosterone glucuronide in Cushing's Syndrome.
- Phenomenology and family history of affective disorder in Cushing's Disease.
- Antihypertensive effects of an aromatase inhibitor in the spontaneously hypertensive rat.
- Unconjugated and conjugated urinary 19-nor-deoxycorticosterone glucosiduronate. Elevated levels in essential hypertension.
- Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I Diabetes.
- Adrenocortical factors in hypertension.
- Plasma immunoreactive gamma melanotropin in patients with idiopathic Hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension.
- Antihypertensive effect of 19-acetylenic-deoxycorticosterone in inbred salt-sensitive rats.
- Adrenocorticosteroid excretion in salt-sensitive and salt-resistant spontaneously hypertensive rats.
- Characterization of the Adrenal 11 beta-hydroxylase in inbred salt-sensitive and resistant rats.
- Chronic mineralocorticoid excess and cardiovascular remodeling.
- 21-deoxyaldosteronism: a new clinical Syndrome.
- Estrogen replacement therapy at menopause. How benefits outweigh risks.
- A-I-D-S: the new endocrine epidemic.
- Dinosaurs and steroids.
- 19-Nor-corticosteroids in genetic hypertension. Effects of inhibitors of 11 beta, 18, 19-hydroxylase activity.
- The superiority of the metyrapone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's Syndrome.
- Amiloride in primary Hyperaldosteronism.
- Amiloride in Bartter's Syndrome.
Schools
Wayne State University School Of Medicine
Boston City Hospital
Faulkner Hospital
Lemuel Shattuck Hospital
Conditions Treated
- Abnormal Thyroid
- Adrenal Insufficiency
- Adrenogenital Disorders
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
- Diabetes Recognition Program
Education
-
Boston University Medical Center -
Wayne State University School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Stewart G. Albert, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Simon J. Fisher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William E. Clutter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip E. Cryer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paraskevi Mentzelopoulos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ruenrudee Suwannasri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amin A. Radparvar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marina Litvin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James N. Heins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matteo G. Levisetti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sina A. Jasim, MD
This Doctor is OpenDoctor Recommended.
|